Cosmos Pharmaceuticals

Who Is Behind the Company

Cosmos Pharmaceuticals was founded in 2017 by William & Mary alumni Alexander Colton and Joseph W. White. The company is headquartered in Middletown, Delaware. The operating team includes Philip McBride as CTO, with additional contributors including Erick Ombego, Vimal Patel, Jesse Wachira, Melissa Fors Shackelford, Josh Bayer, and Abraham Morse.

Data Accuracy: GREEN -- Confirmed across Cosmos Pharmaceuticals website, Daily Press, Crunchbase, and Tracxn.

Inside the Company

Cosmos Pharmaceuticals is a healthtech company building FortisKap, a biometric prescription bottle cap that uses fingerprint authentication, remote locking, and dosing telemetry to address medication adherence and prescription drug misuse. The company has positioned itself as a healthcare data platform, with the cap serving as the data-collection endpoint feeding a secure analytics back end. The product reached a milestone in 2022 when the team announced its first consumer pilot. Capital to date includes a reported $750,000 round in September 2025 and a further $1.3M reported in 2026, with backing from the Delaware SSBCI Accelerator and Seed Capital Program.

Data Accuracy: GREEN -- Confirmed by Cosmos Pharmaceuticals website, Daily Press, Delaware LIVE News, Crunchbase, and Tracxn.

Under the Hood

FortisKap is a prescription cap containing an electronic fingerprint scanner, remote locking mechanism, and the ability to track patient dosing interactions. The cap transmits dispensing events to a secure data center for authorized providers and caregivers. The unit is designed to be reusable, with customers returning the cap for reset and sanitization. The biometric layer functions as a gating mechanism, differentiating the device from passive smart caps that only log openings or send reminders. The company frames its long-term value as a data aggregation and analytics platform.

Data Accuracy: YELLOW -- Product description confirmed by company website and Daily Press; commercial traction and regulatory posture not yet independently corroborated.

Market Research and Opportunity

Medication non-adherence is a significant challenge in U.S. healthcare. Demand drivers include opioid stewardship and controlled-substance diversion, which have pushed payers and prescribers toward technology that demonstrates chain-of-custody. Co-founder Joseph White's pursuit of a 2024-2025 MIT Certificate in Substance Use Disorder Ventures signals a focus on the SUD use case. Competitors include AdhereTech, Pillsy, and Vitality GlowCap. The Delaware SSBCI backing indicates state-level support for the venture.

Metric	Value
Disclosed seed funding (2025)	$750,000
Additional reported round (2026)	$1,300,000

Data Accuracy: YELLOW -- Funding figures corroborated by Tracxn and LinkedIn; market-size claims intentionally not asserted without a named third-party report.

Competition and Substitutes

Cosmos competes in the connected medication-adherence device category, differentiating through biometric access control.

Company	Positioning	Stage / Funding	Notable Differentiator
Cosmos Pharmaceuticals	Biometric prescription cap	Seed, $750K disclosed (with $1.3M reported)	Fingerprint-gated access
AdhereTech	Smart wireless pill bottle	Venture-backed	Pharma-funded deployments
Pillsy	Smart cap and app	Early-stage	Mobile reminder layer
Vitality GlowCap	Light-and-sound cap	Mature	Payer relationships

Data Accuracy: YELLOW -- Subject row confirmed by company website and Tracxn; competitor rows reference category-standard public knowledge.

Opportunity

Cosmos aims to become the default chain-of-custody layer for controlled-substance prescriptions. The biometric mechanism is patented and operational. The company's focus on SUD use cases and its framing as a data platform suggest a path toward verified dispensing records. The realistic near-term win is a Series A priced on a validated pilot outcome.

Data Accuracy: ORANGE -- Scenarios are analyst-constructed from confirmed product, team, and funding facts.

Sources

1. [Cosmos Pharmaceuticals] Cosmos Pharmaceuticals homepage | https://www.cosmosrx.com/
2. [Cosmos Pharmaceuticals] The Cosmos Team | https://www.cosmosrx.com/team
3. [Cosmos Pharmaceuticals] Our Products (FortisKap) | https://www.cosmosrx.com/thefortiskap
4. [LinkedIn] Alexander Colton, Cosmos Rx | https://www.linkedin.com/in/alexander-colton2627/
5. [LinkedIn] Joseph W. White, Co-founder & CIO at Cosmos Pharmaceuticals Inc. | https://www.linkedin.com/in/joseph-w-white-001/
6. [LinkedIn, 2026] Philip McBride, Cosmos Pharmaceuticals Inc. | https://www.linkedin.com/in/philipmcbride/
7. [LinkedIn, 2026] Cosmos Pharmaceuticals LLC company page | https://www.linkedin.com/company/cosmos-pharmaceuticals-llc
8. [Crunchbase, 2026] Cosmos Pharmaceuticals company profile | https://www.crunchbase.com/organization/cosmos-pharmaceuticals
9. [Crunchbase, 2026] Alexander Colton person profile | https://www.crunchbase.com/person/alexander-colton
10. [PitchBook, 2026] Cosmos Pharmaceuticals 2026 Company Profile | https://pitchbook.com/profiles/company/484354-54
11. [Tracxn, 2026] Cosmos Pharmaceuticals 2025 Company Profile, Team & Funding | https://tracxn.com/d/companies/cosmos-pharmaceuticals/__BR8Ek3ciCBfGe-aaukt3AZSGCHTCnLyxdAIw-rRFKYA
12. [Daily Press, January 2022] Two William & Mary alumni patent pill bottle cap requiring a thumbprint to open | https://www.dailypress.com/2022/01/07/two-william-mary-alumni-patent-pill-bottle-cap-requiring-a-thumbprint-to-open/
13. [Delaware LIVE News] Delaware men create pill bottle cap that uses thumbprint to open | https://delawarelive.com/delaware-men-create-pill-bottle-cap-that-uses-thumbprint-to-open/
14. [William & Mary, 2026] Driven by Purpose: The Journey of Cosmos Pharmaceuticals | https://www.wm.edu/offices/entrepreneurship/stories/driven-by-purpose-the-journey-of-cosmos-pharmaceuticals.php
15. [The Startup Club, 2026] Startup of the Week: Cosmos Pharmaceuticals Inc. | https://www.thestartupclub.net/post/startup-of-the-week-cosmos-pharmaceuticals-inc
16. [LeadsForge, 2026] Philip McBride, CTO Cosmos Pharmaceuticals Inc. profile reference | https://leadsforge.io/
17. [RocketReach, 2026] Joseph White professional profile reference | https://rocketreach.co/